Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Riordan Medical Institute (RMI) is a premier regenerative medicine center located in Southlake, Texas, specializing in advanced cellular therapies for orthopedic and spinal conditions. Founded by Dr. Neil Riordan, a globally recognized leader in stem cell research, the institute provides non-surgical alternatives for patients suffering from osteoarthritis, tendonitis, and chronic joint pain. RMI’s treatment protocols utilize autologous bone marrow aspirate concentrate (BMAC), platelet-rich plasma (PRP), and amniotic-derived tissues to stimulate the body’s natural healing processes. The facility combines state-of-the-art diagnostic imaging with minimally invasive biologic injections to improve patient mobility and quality of life. RMI is distinguished by its clinical expertise and its founder's extensive background in mesenchymal stem cell (MSC) research and application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Riordan Medical Institute.